Found: 58
Select item for more details and to access through your institution.
The persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01608-8
- By:
- Publication type:
- Article
Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.
- Published in:
- 2007
- By:
- Publication type:
- journal article
MYC protein expression is associated with poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system.
- Published in:
- APMIS, 2015, v. 123, n. 7, p. 596, doi. 10.1111/apm.12390
- By:
- Publication type:
- Article
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.855730
- By:
- Publication type:
- Article
Low‐risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 776, doi. 10.1111/bjh.18912
- By:
- Publication type:
- Article
Real‐world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR‐2 retrospective chart review study.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 749, doi. 10.1111/bjh.18519
- By:
- Publication type:
- Article
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 1, p. 64, doi. 10.1111/bjh.18597
- By:
- Publication type:
- Article
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 3, p. 306, doi. 10.1111/bjh.18522
- By:
- Publication type:
- Article
Link between disease status at 24 months and mortality in follicular lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 458, doi. 10.1111/bjh.18423
- By:
- Publication type:
- Article
Ocular involvement in patients with primary central‐nervous‐system lymphoma: Analysis of a multicentre study in Spain.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 6, p. 792, doi. 10.1111/bjh.18148
- By:
- Publication type:
- Article
Revised International Prognostic Index and genetic alterations are associated with early failure to R‐CHOP in patients with diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 589, doi. 10.1111/bjh.17858
- By:
- Publication type:
- Article
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 364, doi. 10.1111/bjh.16090
- By:
- Publication type:
- Article
Open questions in watchful waiting for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 679, doi. 10.1111/bjh.14246
- By:
- Publication type:
- Article
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1028, doi. 10.1007/s10637-020-01054-6
- By:
- Publication type:
- Article
Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma.
- Published in:
- Journal of Clinical Apheresis, 2012, v. 27, n. 5, p. 260, doi. 10.1002/jca.21234
- By:
- Publication type:
- Article
A case of non-lethal pulmonary air embolism after leukapheresis catheter removal.
- Published in:
- Journal of Clinical Apheresis, 2005, v. 20, n. 2, p. 93, doi. 10.1002/jca.20055
- By:
- Publication type:
- Article
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1023, doi. 10.1007/s00277-020-04056-9
- By:
- Publication type:
- Article
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2837, doi. 10.1007/s00277-020-04021-6
- By:
- Publication type:
- Article
Routine surveillance imaging in follicular lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Is there a role for the international prognostic index in follicular lymphoma?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Current prognostic and predictive factors in follicular lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Late isolated intraocular relapse of a systemic diffuse large B-cell lymphoma detected by flow cytometry.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Flow cytometry to detect bone marrow involvement by follicular lymphoma.
- Published in:
- Cytometry. Part B, 2022, v. 102, n. 6, p. 427, doi. 10.1002/cyto.b.22098
- By:
- Publication type:
- Article
Front‐line and second‐line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 218, doi. 10.1111/ejh.14219
- By:
- Publication type:
- Article
The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 428, doi. 10.1111/ejh.13556
- By:
- Publication type:
- Article
Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 499, doi. 10.1111/ejh.13392
- By:
- Publication type:
- Article
Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 5, p. 400, doi. 10.1111/ejh.13364
- By:
- Publication type:
- Article
Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 10, p. 3214, doi. 10.1002/cam4.3881
- By:
- Publication type:
- Article
R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 4, p. 1314, doi. 10.1002/cam4.3730
- By:
- Publication type:
- Article
Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first‐line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6955, doi. 10.1002/cam4.2555
- By:
- Publication type:
- Article
The Convective Rainfall Rate from Cloud Physical Properties Algorithm for Meteosat Second-Generation Satellites: Microphysical Basis and Intercomparisons using an Object-Based Method.
- Published in:
- Remote Sensing, 2019, v. 11, n. 5, p. 527, doi. 10.3390/rs11050527
- By:
- Publication type:
- Article
Long‐term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first‐line therapy: A retrospective analysis from two institutions.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 198, doi. 10.1111/ejh.13359
- By:
- Publication type:
- Article
Treatment of localized-stage follicular lymphoma.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 245, doi. 10.1111/ejh.13093
- By:
- Publication type:
- Article
Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 6, p. 487, doi. 10.1111/ejh.12386
- By:
- Publication type:
- Article
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 321, doi. 10.1111/j.1600-0609.2010.01478.x
- By:
- Publication type:
- Article
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 2, p. 102, doi. 10.1111/j.1600-0609.2006.00778.x
- By:
- Publication type:
- Article
HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
- By:
- Publication type:
- Article
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 89, doi. 10.1016/j.clml.2021.08.005
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
- By:
- Publication type:
- Article
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
- By:
- Publication type:
- Article
Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 5, p. 834, doi. 10.1093/cid/ciy542
- By:
- Publication type:
- Article
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 381, doi. 10.1007/s12185-022-03367-z
- By:
- Publication type:
- Article
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
- By:
- Publication type:
- Article
Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 505, doi. 10.1002/hon.3013
- By:
- Publication type:
- Article
Pembrolizumab for refractory primary mediastinal B‐cell lymphoma with central nervous system involvement.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 419, doi. 10.1002/hon.2836
- By:
- Publication type:
- Article